FinancialContent is the trusted provider of stock market information to the media industry.
July 03, 2012 at 11:29 AM EDT
New distribution agreement between tebu-bio and Smartox Biotechnology
PR Log - Jul 03, 2012 - Researchers across Europe are now able to access Smartox Biotechnology’s product portfolio through tebu-bio’s pan-European network of offices.
Smartox Biotechnology (La Tronche, France) is specialized in the production of synthetic peptides issued from venomous animals such as spiders, snails and scorpions. Venomous toxins are known to selectively inhibit specific ion channels and can thus be used as modulators of their function. “Ion channels are important therapeutic targets in drug discovery research, as ion channel dysfunction can lead to a variety of patho-physiological effects”, stated Michel de Waard, Scientific Manager of Smartox Biotechnology. The Ion channel research carried out by Professor Dewaard at the University Joseph Fourier, Grenoble led him to develop important know-how relating to the production and characterization of peptide toxins, research which ultimately led to the creation of Smartox.
The deal between the two organizations came about as a result of the obvious synergy between the two different organization’s core businesses. “We are really excited about our new partnership with tebu-bio” stated Remy Beroud, Leader of Smartox Biotechnology. The last two years has seen a period of intense growth for Smartox with turnover increasing by 200%, and the number of countries we sell to rising to 20. Most importantly of all, we have seen a customer retention rate of over 60%. Time and time again we have seen our customers initially test small samples of our product, only to come back to us to order significant quantities six months later. Our new relationship with tebu-bio will help us open up contact with a vast array of new customers who will also be able to benefit from the quality of our products.
Aurélie Serra, Marketing Manager at tebu-bio commented: “tebu-bio offers hundreds of active enzymes and substrates especially for assay development in pharmaceutical research. The toxins offered by Smartox Biotechnology will complement our portfolio with high quality products for ion channel screenings.” Ali el Bayâ, Protein Sales Manager at tebu-bio adds “We are very pleased to be able to offer our customers throughout Europe access to these high quality products”.
To find out more about Smartox Biotechnology products available from tebu-bio, tebu-bio's website.
tebu-bio is an expert in the supply & distribution of Life Sciences Lab Services & Reagents throughout Europe. Their own laboratories also provide R&D contract services. tebu-bio's online catalogue offers Life Science Researchers access to the most innovative range of products and services.
Smartox Biotechnology's expertise in manufacturing synthetic toxins has been recognized by the French Ministry of Research. “In 2010, we were delighted to receive the OSEO prize for emerging businesses”: stated Remy Beroud, Director at Smartox Biotechnology.
Read Full Story - New distribution agreement between tebu-bio and Smartox Biotechnology | More news from this source
Press release distribution by PRLog
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here